E Frei
- Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments 8
- Oncology top 1%
- Cancer Treatment and Pharmacology 22
- Genetics top 1%
-
- Lymphoma Diagnosis and Treatment 9
- Chemotherapy-induced organ toxicity mitigation 9
-
- Acute Lymphoblastic Leukemia research 19
-
- Lung Cancer Treatments and Mutations 18
- Sarcoma Diagnosis and Treatment 10
-
- Cancer therapeutics and mechanisms 14
- Co-authors
- Norman JaffeDemetrius TraggisRobert J. MayerO. Ross McIntyreSylvia A. HoldenYvonne BishopGeorge OmuraPhilip Schulman
- Cited by
- HematologyOncologyGenetics
- Journals
- Journal of Clinical Oncology (11 papers)Cancer Chemotherapy and Pharmacology (9 papers)Cancer (5 papers)
- Partner nations
- United StatesIndiaGermany
In The Last Decade
E Frei
104 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Hematology 1.6k
- Oncology 2.2k
- Genetics 635
- Pathology and Forensic Medicine 885
- Public Health, Environmental and Occupational Health 1.3k
Countries citing papers authored by E Frei
This map shows the geographic impact of E Frei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Frei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Frei more than expected).
Fields of papers citing papers by E Frei
This network shows the impact of papers produced by E Frei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Frei. The network helps show where E Frei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E Frei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 4 | |
| 2 | 2000 | 6 | |
| 3 | 1996 | 1 | |
| 4 | 1995 | 99 | |
| 5 | 1994 | 28 | |
| 6 | Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemiabreakdown → | 1994 | 1027 |
| 7 | 1994 | 81 | |
| 8 | 1993 | 8 | |
| 9 | 1993 | 19 | |
| 10 | 1993 | 8 | |
| 11 | 1993 | 6 | |
| 12 | 1992 | 9 | |
| 13 | 1992 | 157 | |
| 14 | 1992 | 44 | |
| 15 | Lonidamine as a modulator of alkylating agent activity in vitro and in vivo. | 1991 | 35 |
| 16 | 1991 | 11 | |
| 17 | 1991 | 6 | |
| 18 | 1991 | 6 | |
| 19 | 1989 | 155 | |
| 20 | 1976 | 19 |
About E Frei
E Frei is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine, having authored 104 papers that have together received 6.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (22 papers), Acute Lymphoblastic Leukemia research (19 papers), Lung Cancer Treatments and Mutations (18 papers), Cancer therapeutics and mechanisms (14 papers), Sarcoma Diagnosis and Treatment (10 papers), Lymphoma Diagnosis and Treatment (9 papers), Chemotherapy-induced organ toxicity mitigation (9 papers) and Chronic Myeloid Leukemia Treatments (8 papers). The work is most often cited by research in Hematology (1.6k citations), Oncology (2.2k citations) and Genetics (635 citations). E Frei has collaborated with scholars based in United States, India and Germany. Frequent co-authors include Norman Jaffe, Demetrius Traggis, Robert J. Mayer, O. Ross McIntyre, Sylvia A. Holden, Yvonne Bishop, George Omura, Philip Schulman, Deborah Berg and Bayard L. Powell. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Cancer, Biochemical Pharmacology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.